期刊文献+

结肠癌转移机制及治疗方法研究进展

Research progress on metastasis mechanism and treatment of colon cancer
在线阅读 下载PDF
导出
摘要 结肠癌的转移机制主要包括肿瘤细胞上皮-间质转化(EMT)、肿瘤微环境变化、肠道菌群失调及多种分子通路异常激活等,其中EMT在转移中起关键作用。目前,临床治疗多采用个体化策略,治疗方法包括手术治疗、化疗、靶向治疗和免疫治疗,虽已取得一定疗效,但在耐受性和长期生存率等方面仍存在明显不足。今后需着重关注与结肠癌转移相关的调控网络,以进一步阐述结肠癌的转移机制,为开发、研究更加高效、低毒的治疗方法奠定理论基础。 The metastasis mechanism of colon cancer mainly includes epithelial-mesenchymal transition(EMT)of tumor cells,changes in tumor microenvironment,alteration of intestinal flora and abnormal activation of various molecular pathways,among which EMT plays a key role in metastasis.At present,individualized strategies are mostly used in clinical treatment.Treatment methods include surgery,chemotherapy,targeted therapy and immunotherapy.Although some curative effects have been achieved,there are still obvious deficiencies in tolerance and long-term survival rate.In the future,it is necessary to focus on the regulatory network related to colon cancer metastasis,so as to further explain the metastasis mechanism of colon cancer and lay a theoretical foundation for the development of more efficient and low-toxic treatment methods.
作者 孙立杰 SUN Lijie(Department of Gastroenterology of Affiliated Hospital of Chifeng University,Chifeng 024050 Inner Mongolia,China)
出处 《中国民康医学》 2025年第13期11-14,共4页 Medical Journal of Chinese People’s Health
关键词 结肠癌 转移机制 治疗方法 研究进展 Colon cancer Metastasis mechanism Treatment method Research progress
作者简介 孙立杰(1983.09-),女,汉族,内蒙古赤峰人,硕士研究生,副主任医师,研究方向为消化系统肿瘤的综合治疗。
  • 相关文献

参考文献33

二级参考文献197

  • 1蒋锐沅,蓝巧玉,李春姗,姚菲,董芷辛,严丹,石玮.参一胶囊联合贝伐珠单抗+FOLFIRI方案对晚期转移性结肠癌患者的临床疗效及血清血管生成因子、T淋巴细胞亚群影响的观察[J].中药材,2021,44(6):1504-1510. 被引量:18
  • 2杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1734
  • 3无,邵万金(编译).美国直肠癌治疗临床指南(2005年修订)[J].中华胃肠外科杂志,2006,9(2):182-185. 被引量:16
  • 4Terzie J,Grivennikov S,Karin E,Karin M.Inflammation and colon cancer.Gastroenterology 2010; 138: 2101-2114.e5.
  • 5Tanaka T,Bai Z,Srinoulprasert Y,Yang BG,Hayasaka H,Miyasaka M.Chemokines in tumor progression and metastasis.Cancer Sci 2005; 96: 317-322.
  • 6Yoshimura T,Matsushima K,Oppenheim JJ,Leonard EJ.Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).1987.J Immunol 2005; 175: 5569-5574.
  • 7Huber AR,Kunkel SL,Todd RF 3rd,Weiss SJ.Regulation of transendothelial neutrophil migration by endogenous interleukin-8.Science 1991; 254: 99-102.
  • 8Belperio JA,Keane MP,Arenberg DA,Addison CL,Ehlert JE,Burdick MD,Strieter RM.CXC chemokines in angiogenesis.J Leukoc Biol 2000; 68: 1-8.
  • 9Li A,Varney ML,Singh RK.Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.Clin Cancer Res 2001; 7: 3298-3304.
  • 10Doll D,Keller L,Maak M,Boulesteix AL,Siewert JR,Holzmann B,Janssen KP.Differential expression of the chemokines GRO-2,GRO-3,and interleukin-8 in colon cancer and their impact on metastatic disease and survival.Int J Colorectal Dis 2010; 25: 573-581.

共引文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部